Can Ozempic® Cause Pancreatitis? A Closer Look at the Side Effects

Finding Support on Your Ozempic® Journey

Navigating the complexities of medications like Ozempic® can be daunting, especially when considering potential side effects like pancreatitis. It's important to have reliable support and guidance throughout this journey. At Mochi Health, our experienced providers are dedicated to helping you understand any side effects you may experience and determine whether they warrant concern. With tailored advice and management strategies, we can assist you in optimizing your treatment while prioritizing your health and well-being. Get started today for personalized support on your Ozempic® journey—your health is our priority.

References:

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

2. Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. https://www.ncbi.nlm.nih.gov/books/NBK544016/

3. Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., & Butler, P. C. (2011). Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology, 141(1), 150–156. https://www.gastrojournal.org/article/S0016-5085(11)00172-7/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F

4. Chis, B. A., & Fodor, D. (2018). Acute pancreatitis during GLP-1 receptor agonist treatment. A case report. Clujul medical (1957), 91(1), 117–119. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29440961/

5. Consoli A., Formoso G. Potential side effects to GLP-1 agonists: understanding their safety and tolerability Expert Opin Drug Saf, 14 (2015), pp. 207-218. https://www.tandfonline.com/doi/full/10.1517/14740338.2015.987122

6. Lai S.W., Muo C.H., Liao K.F., SungF.C., Chen P.C. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan Am J Gastroenterol, 106 (2011), pp. 1697-1704. https://journals.lww.com/ajg/abstract/2011/09000/risk_of_acute_pancreatitis_in_type_2_diabetes_and.21.aspx

7. Brady, Sean, et al. “GLP-1 Agonist Use in a Patient with an Explainable Cause of Pancreatitis.” AACE Clinical Case Reports, Elsevier, 28 Dec. 2020. https://www.aaceclinicalcasereports.com/article/S2376-0605(20)30288-1/fulltext

8. Matveyenko, A. V., Dry, S., Cox, H. I., Moshtaghian, A., Gurlo, T., Galasso, R., Butler, A. E., & Butler, P. C. (2009). Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes, 58(7), 1604–1615. https://doi.org/10.2337/db09-0058

9. Mahase, Elisabeth. “GLP-1 Agonists Linked to Adverse Gastrointestinal Events in Weight Loss Patients.” BMJ, 9 Oct. 2023, doi:10.1136/bmj.p2330. https://www.bmj.com/content/383/bmj.p2330.long

This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.